EYEG — AB Corporate Bond ETF

EYEGAB Corporate Bond ETF

35.17USD+0.17%Mkt Cap: —P/E: —Last update: 2026-05-22

The fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers.…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)—

Revenue/Share—

Last Price35.17 USD

Fiscal Year End—

MR Quarter—

Employees—

CountryUS

SectorHealth Care

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B—

EPS (TTM)—

EPS (Forward)—

52W Range

34.7124% of range36.63

52W High36.63 USD

52W Low34.71 USD

Profitability

Gross Margin—

Oper. Margin—

EBITDA Margin—

Profit Margin—

ROE—

ROA—

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF—

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio—

Quick Ratio—

Book Value/Sh—

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield4.98%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float—

Insiders—

Institutions—

Technical

SMA 5035.27 (-0.3%)

SMA 20035.79 (-1.8%)

Beta—

S&P 52W Chg—

Avg Vol (30d)300

Avg Vol (10d)440

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—